BRIANA RANDOLPH: Open Payments
NPI 1093412900 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$294 in 14 payments from 8 companies in 2025. Trend: 2023 $273 · 2024 $277 · 2025 $294
Food & beverage: $294
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $71 |
| Lilly USA, LLC | 4 | $66 |
| ABBVIE INC. | 2 | $62 |
| Corcept Therapeutics | 1 | $24 |
| Acella Pharmaceuticals, LLC | 1 | $23 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: Rybelsus, UBRELVY, MOUNJARO, Korlym, NP Thyroid 60, Cequa, The Cologuard Plus Collection Kit, OTEZLA.
Industry payments across TX — which companies pay providers there.
